Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

528
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

398
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
398
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

568
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
568

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trial trustworthiness assessment: commentary on the Cochrane 2025 systematic review on calcium supplementation during pregnancy.

Reproductive health·2026
Same author

Interventions for treating posterior cruciate ligament injuries of the knee in adults: A systematic review and meta-analysis protocol.

PloS one·2025
Same author

Brazilian Public Health System protocol for the diagnosis, treatment, and clinical monitoring of acute ischemic stroke.

Arquivos de neuro-psiquiatria·2025
Same author

Effects of Photobiomodulation on Burning Mouth Syndrome: A Systematic Review and Meta-Analysis.

Journal of oral rehabilitation·2025
Same author

"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": comment from Flumignan et al.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Vaccines for preventing herpes zoster in older adults.

The Cochrane database of systematic reviews·2023
Same journal

Impact of physical activity associated with bariatric surgery on systemic arterial hypertension control: a systematic review.

Sao Paulo medical journal = Revista paulista de medicina·2026
Same journal

Non-surgical facial harmonization for gender affirmation and psychosocial well-being in transmasculine persons: an exploratory mixed-methods study.

Sao Paulo medical journal = Revista paulista de medicina·2026
Same journal

Connecting care-telemedicine breaks barriers for low-income Brazilians battling breast cancer: a prospective cohort study.

Sao Paulo medical journal = Revista paulista de medicina·2026
Same journal

The effects of agmatine treatment on cisplatin-induced hepatotoxicity: an experimental rat study.

Sao Paulo medical journal = Revista paulista de medicina·2026
Same journal

Clinical features of chronic tension-type headache combined with hyperacusis: a cross-sectional study.

Sao Paulo medical journal = Revista paulista de medicina·2026
Same journal

Health outcomes and medical response during a military deployment in Iraq: a prospective observational study of morbidity, treatments, and evacuations.

Sao Paulo medical journal = Revista paulista de medicina·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

Statins for aortic valve stenosis.

Luciana Thiago, Selma Rumiko Tsuji, Jonathan Nyong

    Sao Paulo Medical Journal = Revista Paulista De Medicina
    |January 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Statins show no significant effect on slowing the progression of aortic valve stenosis or reducing the need for valve replacement. Evidence quality is low to moderate, indicating uncertainty about their overall benefit.

    More Related Videos

    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
    12:17

    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

    Published on: May 21, 2017

    11.9K
    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
    05:47

    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

    Published on: May 10, 2021

    4.7K

    Related Experiment Videos

    Last Updated: Mar 9, 2026

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
    08:50

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

    Published on: March 26, 2018

    12.4K
    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
    12:17

    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

    Published on: May 21, 2017

    11.9K
    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
    05:47

    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

    Published on: May 10, 2021

    4.7K

    Area of Science:

    • Cardiovascular Medicine
    • Pharmacology
    • Clinical Trials

    Background:

    • Aortic valve stenosis (AVS) is a prevalent valvular heart disease in the USA and Europe.
    • AVS shares similarities with atherosclerotic disease, prompting investigation into statin efficacy.

    Purpose of the Study:

    • To evaluate the effectiveness and safety of statins in treating aortic valve stenosis.
    • To assess statins' impact on AVS severity, need for valve replacement, and cardiovascular outcomes.

    Main Methods:

    • Systematic review and meta-analysis of four randomized controlled trials (RCTs).
    • Included 2360 participants comparing statins with placebo or usual care.
    • Primary outcomes: AVS severity (mean pressure gradient, valve area, aortic jet velocity), freedom from valve replacement, cardiovascular death. Secondary outcomes: hospitalization, mortality, adverse events, quality of life.

    Main Results:

    • Low-quality evidence indicates statins do not significantly alter AVS severity.
    • Moderate-quality evidence shows no effect on freedom from valve replacement or muscle pain.
    • Low to very low-quality evidence shows uncertainty regarding cardiovascular death and hospitalization rates.

    Conclusions:

    • Current evidence suggests uncertainty about the effectiveness of statins for aortic valve stenosis.
    • The quality of evidence ranges from moderate to very low, supporting existing guidelines that lack specific clinical treatment options for AVS.